Exposure to statins and risk of common cancers: a series of nested case-control studies.

BMC Cancer · 2011 · PMC3197575 · PMID 21943022

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

4.2.6 Haematological malignancies There was a 22% reduced blood cancer risk for overall statin use (AOR 0.78, 95%CI 0.71 to 0.86, P < 0.001) and a 24% reduction for patients with statin prescriptions of more than a year (AOR 0.76, 95%CI 0.68 to 0.85), with a significant trend for duration of use (P trend < .001).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.